Dash Pharms Natco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DASH PHARMS NATCO, and what generic and branded alternatives to DASH PHARMS NATCO drugs are available?
DASH PHARMS NATCO has five approved drugs.
Drugs and US Patents for Dash Pharms Natco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dash Pharms Natco | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 203507-001 | Nov 20, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Dash Pharms Natco | BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 075831-002 | Dec 14, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Dash Pharms Natco | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074866-001 | Nov 26, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Dash Pharms Natco | ALBUTEROL SULFATE | albuterol sulfate | TABLET;ORAL | 072894-002 | Jan 17, 1991 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Dash Pharms Natco | BALSALAZIDE DISODIUM | balsalazide disodium | CAPSULE;ORAL | 077807-001 | Dec 28, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Dash Pharms Natco | BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 075831-001 | Dec 14, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Dash Pharms Natco | ALBUTEROL SULFATE | albuterol sulfate | TABLET;ORAL | 072894-001 | Jan 17, 1991 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.